Physician profile
Edith Rodriguez
NPI 1346588183
$3,389.48
in general payments reported to CMS, 2019-2025
38 companies · $737 in 2025
The $737 reported for 2025 was more than what 80% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $561 · 2022: $363 · 2023: $827 · 2024: $902 · 2025: $737.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,466.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,465.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $573.48 | 2021-2025 | Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $402.25 | 2021-2025 | Breztri, Farxiga, Lokelma |
| Amgen INC. | $400.87 | 2021-2025 | Repatha, Otezla, Otezla |
| Glaxosmithkline, LLC. | $360.95 | 2021-2025 | Trelegy Ellipta |
| Lilly USA, LLC | $228.77 | 2021-2025 | Jardiance, Mounjaro |
| Abbvie INC. | $176.33 | 2021-2025 | |
| Otsuka America Pharmaceutical, INC. | $110.00 | 2024-2025 | Rexulti |
| Pfizer INC. | $92.22 | 2023-2025 | |
| Exact Sciences Corporation | $81.21 | 2024-2025 | Cologuard Collection Kit |
| Axsome Therapeutics, INC. | $80.73 | 2022-2025 | Auvelity |
| Bayer Healthcare Pharmaceuticals INC. | $74.17 | 2023 | |
| Mannkind Corporation | $67.60 | 2024-2025 | |
| Medtronic, INC. | $54.16 | 2023 | Minimed 780g |
| Novartis Pharmaceuticals Corporation | $51.83 | 2024-2025 | |
| Eisai INC. | $48.39 | 2024-2025 |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edith Rodriguez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.